Abstract

Efficacy outcome measures were estimated by calculating the Mean Difference (MD) values and their 95% Confidence Intervals (CI) by both fixed and random effect models using Revman 5.4.1 software. Potential articles selected by this method were then screened in their full text form for availability of required data on population, intervention, comparator, outcome along with trial design and other parameters to assess their eligibility for inclusion as per preset eligibility criteria. Trials meeting all eligibility criteria were selected and data on baseline demographic, clinical data, study characteristic data, intervention data, and data required for estimation of outcome measures were collected by both authors individually. Synthesis of Results and Statistical Methods Used Efficacy outcome measures were estimated by calculating the Mean Difference (MD) values and their 95% Confidence Intervals (CI) by both fixed and random effect models using Revman 5.4.1 software.

Details

Title
Bumetanide for autism spectrum disorders: A systematic review and meta-analysis
Author
Hiremath, Sharanabasayyaswamy Basayya 1 ; Devendrappa, Srinivas Lokikere 2 

 Department of Pharmacology, Kodagu Institute of Medical Sciences, Madikeri, Karnataka, India 
 Department of Pharmacology, Jagadguru Jayadeva Murugarajendra Medical College, Davangere, Karnataka, India 
Pages
717-722
Section
SYSTEMATIC REVIEW
Publication year
2022
Publication date
2022
Publisher
Association of Physiologists, Pharmacists & Pharmacologists
ISSN
23204672
e-ISSN
22313206
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2673383225
Copyright
© 2022. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.